SEC Form 4 · accession 0001209191-19-017409
Senseonics Holdings, Inc. · SENS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francine Kaufman
Officer — Chief Medical Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001616543
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $3.07 | Mar 4, 2019 | A | 550,000 | A | — | Mar 3, 2029 | Common Stock | 550,000 | 550,000 | D |
Explanation of responses
- F1The exercise price is equal to the closing price of the issuer's common stock on the NYSE American on the date of grant, March 4, 2019.
- F2One-fourth of the shares vest on March 4, 2020, with the remaining shares vesting in 36 equal installments at the end of the calendar month for each month after March 4, 2020, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.